Naoya Imanaga
Overview
Explore the profile of Naoya Imanaga including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
98
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
2.
Koizumi H, Imanaga N, Terao N
Jpn J Ophthalmol
. 2024 Aug;
68(5):419-428.
PMID: 39150610
Central serous chorioretinopathy (CSC) is a common disorder characterized by serous retinal detachment. Several studies using indocyanine green angiography (ICGA) have revealed that choroidal filling delay, choroidal vascular dilation, and...
3.
Oshiro A, Imanaga N, Terao N, Koizumi H
Retina
. 2024 Jul;
44(8):1344-1350.
PMID: 39047128
Purpose: To evaluate changes in scleral thickness in Vogt-Koyanagi-Harada (VKH) disease. Methods: This study included 34 eyes of 17 treatment-naïve patients with acute-phase VKH disease. Scleral thickness and the presence...
4.
Sawaguchi S, Terao N, Imanaga N, Wakugawa S, Miyara Y, Oshiro A, et al.
Graefes Arch Clin Exp Ophthalmol
. 2024 Jul;
262(12):3805-3814.
PMID: 38995353
Purpose: To evaluate the changes in choroidal thickness 1 year after half-dose photodynamic therapy (PDT) for central serous chorioretinopathy (CSC) using widefield swept-source optical coherence tomography. Methods: We retrospectively reviewed...
5.
Shimabukuro W, Chinen Y, Imanaga N, Yanagi K, Kaname T, Nakanishi K
Pediatr Nephrol
. 2024 Mar;
39(8):2351-2353.
PMID: 38467926
Renal coloboma syndrome (RCS) and dominant optic atrophy are mainly caused by heterozygous mutations in PAX2 and OPA1, respectively. We describe a patient with digenic mutations in PAX2 and OPA1....
6.
Imanaga N, Terao N, Wakugawa S, Miyara Y, Sawaguchi S, Oshiro A, et al.
Am J Ophthalmol
. 2024 Jan;
261:103-111.
PMID: 38281567
Purpose: To evaluate the association between scleral thickness and a newly developed multimodal imaging-based classification of central serous chorioretinopathy (CSC). Design: Retrospective, cross-sectional study. Methods: This study included 217 eyes...
7.
Maehira M, Oshiro A, Imanaga N, Yamauchi Y, Koizumi H
Am J Ophthalmol Case Rep
. 2023 Sep;
32:101929.
PMID: 37771387
Purpose: To report Vogt-Koyanagi-Harada (VKH) disease in a patient with extreme anisometropia. Observations: A 56-year-old woman was referred to our hospital. Her past medical history was significant for amblyopia in...
8.
Aichi T, Terao N, Imanaga N, Sawaguchi S, Wakugawa S, Miyara Y, et al.
Retina
. 2023 Jun;
43(9):1573-1578.
PMID: 37262427
Purpose: The sclera is reportedly thicker in eyes with central serous chorioretinopathy (CSC) than in healthy control eyes. We compared the scleral thicknesses of the affected and unaffected fellow eyes...
9.
Imanaga N, Terao N, Sonoda S, Sawaguchi S, Yamauchi Y, Sakamoto T, et al.
Invest Ophthalmol Vis Sci
. 2023 Jan;
64(1):16.
PMID: 36662534
Purpose: Central serous chorioretinopathy (CSC) is a retinal disorder characterized by serous retinal detachment with or without pigment epithelial detachment in the posterior pole of the eye. We aimed to...
10.
Sawaguchi S, Terao N, Imanaga N, Wakugawa S, Tamashiro T, Yamauchi Y, et al.
Ophthalmol Sci
. 2022 Oct;
2(2):100124.
PMID: 36249703
Purpose: To evaluate and compare the scleral thickness of patients with idiopathic central serous chorioretinopathy (iCSC) and steroid-induced central serous chorioretinopathy (sCSC) using anterior-segment OCT. Design: Retrospective, comparative study. Participants:...